We are live on ! Find out more
SOA

Sea Otter Advisors Portfolio holdings

AUM $1.78M
1-Year Est. Return 2.28%
This Fund
S&P 500
This Quarter Est. Return
+6.97%
1 Year Est. Return
-2.28%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$179M
AUM Growth
-$1.19M
Cap. Flow
-$4.53M
Cap. Flow %
-2.53%
Top 10 Hldgs %
49.31%
Holding
319
New
54
Increased
36
Reduced
11
Closed
61
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KYCHW
226
DELISTED
Keyarch Acquisition Corporation Warrant
KYCHW
$1.76K ﹤0.01%
42,097
GLSTW
227
DELISTED
Global Star Acquisition, Inc. Warrants
GLSTW
$1.71K ﹤0.01%
60,000
CFFSW
228
DELISTED
CF Acquisition Corp. VII Warrant
CFFSW
$1.49K ﹤0.01%
26,666
DHAIW
229
DELISTED
DIH Holding US Inc Warrants
DHAIW
$1.43K ﹤0.01%
86,900
OTECW
230
DELISTED
OceanTech Acquisitions I Corp. Warrant
OTECW
$1.38K ﹤0.01%
50,000
ABVEW
231
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$1.35K ﹤0.01%
15,000
CETUW
232
DELISTED
Cetus Capital Acquisition Corp. Warrant
CETUW
$1.35K ﹤0.01%
45,000
HSPOW
233
DELISTED
Horizon Space Acquisition I Corp Warrant
HSPOW
$1.35K ﹤0.01%
33,800
FAASW
234
DELISTED
DigiAsia Corp Warrant
FAASW
$1.3K ﹤0.01%
50,000
AOGOW
235
DELISTED
Arogo Capital Acquisition Corp. Warrant
AOGOW
$1.25K ﹤0.01%
25,000
ASCA
236
DELISTED
A SPAC I Acquisition Corp. Class A Ordinary Share
ASCA
$1.19K ﹤0.01%
110
IXAQW
237
DELISTED
IX Acquisition Corp. Warrant
IXAQW
$1.12K ﹤0.01%
37,400
DUETW
238
DELISTED
DUET Acquisition Corp. Warrant
DUETW
$1.08K ﹤0.01%
28,975
CLDI.WS
239
DELISTED
Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00
CLDI.WS
$1.07K ﹤0.01%
+4,871
New +$891
ONMDW icon
240
OneMedNet Corp Warrant
ONMDW
$994K
$900 ﹤0.01%
20,000
OIOWW
241
OIO Group Warrants
OIOWW
$896 ﹤0.01%
+45,931
New +$1.35K
AERTW
242
Aeries Technology Warrant
AERTW
$887K
$889 ﹤0.01%
20,777
INTEW
243
DELISTED
Integral Acquisition Corporation 1 Warrants
INTEW
$865 ﹤0.01%
25,000
MAQCW
244
DELISTED
Maquia Capital Acquisition Corporation Warrant
MAQCW
$794 ﹤0.01%
12,500
KRNLW
245
DELISTED
Kernel Group Holdings, Inc. Warrants
KRNLW
$744 ﹤0.01%
12,500
HHLA.WS
246
DELISTED
HH&L Acquisition Co. Redeemable warrants, each warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HHLA.WS
$719 ﹤0.01%
12,500
HPLTW
247
DELISTED
Home Plate Acquisition Corporation Warrant
HPLTW
$708 ﹤0.01%
20,584
SAGAR
248
DELISTED
Sagaliam Acquisition Corp. Rights
SAGAR
$698 ﹤0.01%
5,395
PUCKW
249
DELISTED
Goal Acquisitions Corp. Warrant
PUCKW
$693 ﹤0.01%
25,000
AMODW
250
Alpha Modus Holdings Warrant
AMODW
$310K
$650 ﹤0.01%
25,000

Similar funds

Sea Otter Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Sea Otter Advisors held 319 positions worth $179M, down 0.66% from $180M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sea Otter Advisors's Q3 2023 filing shows 54 new, 36 increased, 11 reduced and 61 closed positions. Its largest new stake was Juniper II Corp.: 400,000 shares worth $4.24M. The largest sale was Apollo Strategic Growth Capital II, an estimated $5.46M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

  • Sea Otter Advisors's largest Q3 2023 buy was Juniper II Corp.: 400,000 shares worth $4.24M.
  • Sea Otter Advisors added most to Kayne Anderson NextGen Energy & Infrastructure, Inc. in Q3 2023, an estimated $2.16M increase.
  • Sea Otter Advisors's biggest Q3 2023 reduction was Center Coast Brookfield MLP & Energy Infrastructure Fund, cutting an estimated $1.36M.
  • Sea Otter Advisors fully exited Apollo Strategic Growth Capital II in Q3 2023, selling an estimated $5.46M.
  • Sea Otter Advisors's ten largest holdings make up 49% of its $179M portfolio in Q3 2023.
  • Sea Otter Advisors opened 54 new positions and closed 61 in Q3 2023.
  • Sea Otter Advisors's portfolio value fell 0.66% quarter-over-quarter to $179M.

Based on Sea Otter Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.